Sign up for the QMED & MD+DI Daily newsletter.
Location: Brisbane, CaliforniaProducts: Molecular diagnostics company focused on tests for heart transplant recipients
December 15, 2014
1 Min Read
Location: Brisbane, California
Products: Molecular diagnostics company focused on tests for heart transplant recipients
Date of IPO: July 16
IPO Offer Price: $10
Deal Size: $40 million
Returns: -30%
You May Also Like